PrecisionLife is a precision medicine company that generates insights into complex chronic diseases to enhance drug development and personalize healthcare.

PrecisionLife

PrecisionLife | 4,730 followers on LinkedIn. The clinical-stage precision medicine company for chronic diseases. Creating better treatment options for patients. | PrecisionLife is the clinical-stage precision medicine company for complex chronic diseases. Creating better diagnostic tools and more personalized treatment options for patients with unmet medical needs.

Our analytics and AI is unique in its understanding of causal disease biology.

Chief Business and Investment Officer @ PrecisionLife | Angel Investor

Rowan Gardner

Chief Medical Officer @ PrecisionLife | MBA from INSEAD

Veronique Bouchet

Simon Beaulah

Chief Technology Officer at PrecisionLife

Mark Strivens

New transformational AI-led #PrecisionNeuroscience #ALSresearch study by the PrecisionLife team discovers actively protective biology, novel causal targets, drug repurposing candidates and mechanistic patient stratification biomarkers in #MND #ALS . Read about our findings and view the study presented at the Northeast ALS Consortium (NEALS) Research Meeting via the link below. ➡️ https://lnkd.in/eHQjJQyw #MNDresearch #PrecisionMedicine Please share Ammar Al-Chalabi Brian Dickie Motor Neurone Disease (MND) Association The ALS Association Sophie Nyberg Ahmad Al Khleifat UK MND Research Institute (UK MND RI)

AI Driven Drug Discovery - 💡 Learn about our AI-driven precision medicine approach to stratify chronic disease populations by disease mechanism and map targets, trials and treatments to the patients who will benefit. 💊 See how we're de-risking biopharma innovation and increasing probability of success for drug developers creating life-changing therapies in complex chronic diseases. ➡️ Join Simon Beaulah , SVP Healthcare at PrecisionLife , and leaders from AI and pharma to shape drug discovery's future at AI Driven Drug Discovery Summit 2024 in Boston. Full details at: https://lnkd.in/g4VMjN3N #PrecisionMedicine #AIDrugDiscovery #DrugDevelopment #Biopharma

**Updates from CNS Summit Innovation Showcase Award-Winning Companies** This promises to be a fantastic session with updates from leading life science innovators and disruptors who are finding new ways to do things better. Stephanie Pfister | AbbVie Ardy Arianpour | SEQSTER Derk Arts, | Castor Meghan Conroy | CAPTUREPROOF Steve Gardner | PrecisionLife Join us on stage from 1:00 PM – 1:50 PM on Tuesday, November 12 at #CNSSummit2024 .

⏪ Last year, we were honored to win the CNS Summit Innovation Showcase Award for our groundbreaking disease studies which build a deeper understanding of the drivers of complex disease biology. ⏩ We're now translating these insights into clinical practice - creating accurate diagnostics tools that are more personalized and clinically actionable to predict and prevent diseases that affect billions of people and account for over 80% of healthcare spending. This is #PrecisionMedicine . Watch our Innovation Showcase winning presentation and join us at #CNSSummit2024 to discover more. https://hubs.ly/Q02Xgb4N0

We're returning to CNS Summit in Boston to present our latest #PrecisionNeuroscience - At #CNSSummit2024 we'll share how we're driving #precisionmedicine in neurological, psychiatric and neurodegenerative diseases. And after winning last year's #InnovationShowcase award, our CEO Steve Gardner will also provide an update on our precision medicine programs that are creating better, more personalized #diagnostics tools and treatment options for people with unmet medical needs. Find out more and see when PrecisionLife is presenting: ➡️ https://hubs.ly/Q02Xgbt90

We're in Stockholm for #BIOEurope to meet with... 🔘 #Biopharma seeking to improve probability of R&D success 🔘 #Diagnostics companies partnering to advance novel diagnostics 🔘 #Investors with an interest in clinical stage AI companies Come & learn about AI-led #PrecisionMedicine for complex chronic diseases. Send us a message in the partnering platform or email bio@precisionlife.com . ▶ https://lnkd.in/dEHwkCHK

**AI in Healthcare Webinar** Chronic diseases affect billions of patients and account for over 80% of healthcare spending globally. With unique insights into the drivers of disease, PrecisionLife is leading a biology revolution, at the forefront of global efforts to #predict and #prevent chronic diseases. Combining unrivalled precision medicine analytics and #AI , we're creating a new generation more accurate and personalized #diagnostics tools and #drugs to not only treat, but also delay onset and prevent progression of major chronic diseases. This is #PrecisionMedicine . #Investors - learn more by joining our co-founders Steve Gardner and Rowan Gardner in discussion with Mark Dainty of BlueBox Asset Management . ➡ Register at: https://lnkd.in/e_V-tuBT

#MetX , funded by the Metrodora Foundation and in partnership with Metrodora Institute and PrecisionLife , is a first-of-its-kind study to create more accurate diagnostics and precision therapies for patients living with complex multisystem disorders. The first participants have begun receiving their #WGS results in detailed research reports with PrecisionLife insights that identify the possible underlying mechanisms of their disease - a significant breakthrough in #PrecisionMedicine for complex diseases. Read more in the Metrodora Foundation newsletter ft. Amy Rochlin and Steve Gardner . ➡️ https://lnkd.in/ebgrcAve

*** For Professional Investors Only *** 🧬 Are you interested in how #AI will impact #healthcare and bio-pharma R&D? Then this webinar is for you! ☎️ We receive a lot of questions about whether #AI will transform R&D and #healthcare , and what it means for investors in the #healthcare , #biotech and #technology sectors. To provide insight on this topic, we are delighted to invite you to a webinar with leading industry experts with experience in AI, healthcare and drug development. During the webinar, Mark Dainty , Lead PM of the #BlueBox Precision Medicine Fund, will discuss this fascinating area with Steve Gardner , and Rowan Gardner , CEO and CBO of PrecisionLife . Participants will hear more about the practical use of AI in drug development, the benefit to companies, patients and investors and how #PrecisionLife is using it. If you would like to join us, please head over to the event page and fill in the form available via the external events page. #webinar #AI #precisionmedicine #investing #funds #bbam #bbpm

PREC

COM:PRECISIONLIFE

PrecisionLife

Financials Not Available